Showing results (421-430 of 437) with videos related to

Sort By:
Pageof 44
International Journal of Occupational Medicine and Environmental Health|April 7, 2011
Occupational exposure to trichloroethylene and cancer risk for workers at the Paducah Gaseous Diffusion PlantDebra E Bahr, Timothy E Aldrich, Dazar Seidu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2026
Targeting CD24 activates macrophages to reduce tumor burden in preclinical models of solid tumorsDouglas V Faget, Rachel E Brewer, Joseane Sampaio, et al.
Mbio|October 3, 2019
Ecological and Genomic Attributes of Novel Bacterial Taxa That Thrive in Subsurface Soil HorizonsTess E Brewer, Emma L Aronson, Keshav Arogyaswamy, et al.
Blood|June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanomaGerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 13, 2023
A Combination of Distinct Vascular Stem/Progenitor Cells for Neovascularization and Ischemic RescueLiming Zhao, Andrew S Lee, Koki Sasagawa, et al.
Plos One|February 6, 2013
Combining functional and structural genomics to sample the essential Burkholderia structomeLoren Baugh, Larry A Gallagher, Rapatbhorn Patrapuvich, et al.
Nature|August 12, 2021
Aged skeletal stem cells generate an inflammatory degenerative nicheThomas H Ambrosi, Owen Marecic, Adrian McArdle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2021
Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-βJonathan D Silk, Rachel J M Abbott, Katherine J Adams, et al.
Journal of Medicinal Chemistry|February 1, 2024
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell MalignanciesDaniel W Robbins, Mark A Noviski, Ying Siow Tan, et al.
Science Translational Medicine|August 9, 2013
Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cellsBrian J Cameron, Andrew B Gerry, Joseph Dukes, et al.
Pageof 44